Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sleep and Wake Countermeasures for Artemis: In-laboratory Study

NCT06531733 is registered in ClinicalTrials.gov with National Aeronautics and Space Administration (NASA) as lead sponsor.

NCT NCT06531733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06531733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sleep and Wake Countermeasures for Artemis: In-laboratory Study
Lead sponsor
National Aeronautics and Space Administration (NASA)
Phase
Not applicable
Overall status
Unknown status
Start date
June 22, 2024
Completion date
June 1, 2025
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue